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Introduction
Forgetfulness, difficulties instilling eye drops and difficulties with 
the medication schedule are the main factors that affect 
adherence to taking glaucoma treatment.1 Patients with poor 
adherence (80% or less) have been found to have greater visual 
field severity or report to be in poor health.2,3 Failure to take 
medications as prescribed can result in increased complications, 
worsened health status, and higher overall healthcare costs.4
Health behaviour models including the use of education tools 
and identifying motivation factors linked to adherence may 
facilitate the development of a tailored approach, accounting for 
individual and age-related differences.5,6
Purpose
• To assess levels of compliance to ocular medications for 
patients with glaucoma and ocular hypertension.
• To determine the common obstacles to medications adherence 
and develop strategies to help improve adherence.
Methods
Over a period of eight weeks in late 2018, patients who attended 
the treatment and concordance clinic at the glaucoma outpatient 
department of St Thomas’ Hospital and were on treatment were 
investigated. Patients who did not instill their own drops due to 
severe cognitive impairment or had physical disabilities 
preventing them from doing so were excluded from the study,
Data gathered over the previous month included compliance to 
treatment, frequency of non-compliance (if any) and any 
reasons for non-compliance. Information on age, ethnicity, 
gender, ocular diagnosis, visual field mean deviation as a level 
of glaucoma disease severity and the presence of any physical 
dexterity problems was also collected.
Results
Data obtained for fifty patients are summarised in Table 1. Figure 1 
shows the frequency of drops missed over the last month for the non 
compliant group. Reasons reported for missing drops are outlined in 
Table 2. Some of the ‘other reasons’ for non compliance are shown in 
the speech bubbles.
Conclusion
A significant number of our patients reported poor compliance 
with their drop regime (52%) with over a third missing their 
medication multiple times per month and 15% admitting to not 
instilling drops 11- 20 days a month. The non-compliant patients 
were older (p=0.04), more likely to be non-white (Odds 
Ratio=1.9) and be on multiple drops (Odds Ratio=3.3) than the 
compliant group.
The main reason for non compliance was forgetting to instil the 
drops. It follows that interventions such as smartphone 
adherence apps,7 reminder gadgets or alternatives to medical 
treatment such as Select Laser Trabeculoplasty (SLT) should 
be considered.      
As glaucoma progression has been shown to be linked to poor 
compliance4 this may have implications for the future 
management and subsequent quality of life for these patients. 
Further work is therefore needed in identifying these patients at 
an earlier stage and developing more affective individualized 
adherence management plans. 
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63 [55- 70] 75 [59- 82] P=0.04**
White (%) 17 (34) 10 (42) 7 (27) NS*
Black (%) 26 (52) 10 (42) 16 (62) NS*
POAG (%) 29 (58) 15 (63) 14 (54) NS*
Glaucoma Severity




-9.4 (7.7) -11.7 (10.2) NS**
Physical difficulties 
(%)
5 (10) 1 (4) 4 (15) NS*
Taking  > 2 bottles 
(%)  
8(16) 2(8) 6 (23) NS*
“I don’t instil 
my drops if 
my eyes 
feel good“
“I struggle to 
put in my 
drops“
“I don’t know 




Table 1 Significance tests: Chi-squared test*, independent samples T Test**, NS=not significant




Ran out 2 (8)




Using wrong drops 1 (4)
Other reasons 7 (27)
Table 2
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